Point72 Hong Kong’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,300
Closed -$423K 753
2022
Q3
$423K Buy
2,300
+400
+21% +$79.7K 0.01% 795
2022
Q2
$319K Sell
1,900
-5,900
-76% -$1.27M 0.01% 846
2022
Q1
$1.96M Buy
7,800
+4,100
+111% +$1.03M 0.07% 335
2021
Q4
$951K Sell
3,700
-2,800
-43% -$685K 0.03% 572
2021
Q3
$1.58M Buy
6,500
+100
+2% +$24.4K 0.05% 566
2021
Q2
$1.32M Buy
+6,400
New +$1.3M 0.04% 604
2021
Q1
Sell
-42,400
Closed -$6.97M 1972
2020
Q4
$6.97M Buy
+42,400
New +$6.2M 0.31% 41

Other funds holding HCA

Point72 Hong Kong's HCA Position: Q2 2024 in Review

Point72 Hong Kong sold out of HCA Healthcare (HCA) in Q2 2024, closing a stake of 10,772 shares — an estimated $3.59M sold.

Point72 Hong Kong first reported a position in HCA in Q3 2014 and held it in 19 quarters. The position peaked at $13.2M in Q2 2022. 1,156 funds tracked by Wall St. Rank hold HCA as of Q2 2024.

  • Point72 Hong Kong reported no remaining HCA Healthcare position as of Q2 2024 after selling out during the quarter.
  • Point72 Hong Kong sold 10,772 HCA Healthcare shares in Q2 2024, an estimated $3.59M.
  • Point72 Hong Kong first reported a position in HCA Healthcare in Q3 2014 and held it in 19 quarters.
  • Point72 Hong Kong's HCA Healthcare position peaked at $13.2M in Q2 2022.
  • 1,156 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2024.

Based on Point72 Hong Kong's 13F filing for Q2 2024, filed 14 Aug 2024.